Drug
NPC-01
NPC-01 is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
100%(4 trials)
Phase Distribution
Ph phase_3
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
4(100.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 34 (100.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_3
Pharmacokinetics of NPC-01 After Single Oral Administration in Healthy Female Volunteers
NCT01246791
completedphase_3
Efficacy and Safety, Long-Term Study of NPC-01 to Treat Dysmenorrhea Associated With Endometriosis
NCT00902746
completedphase_3
Pharmacodynamics of NPC-01/IKH-01; Effect of NPC-01/IKH-01 on Sexual Hormone Concentrations in Healthy Female Volunteers
NCT01253824
completedphase_3
Efficacy and Safety Study of NPC-01 to Treat Dysmenorrhea
NCT01129102
Clinical Trials (4)
Showing 4 of 4 trials
NCT01246791Phase 3
Pharmacokinetics of NPC-01 After Single Oral Administration in Healthy Female Volunteers
NCT00902746Phase 3
Efficacy and Safety, Long-Term Study of NPC-01 to Treat Dysmenorrhea Associated With Endometriosis
NCT01253824Phase 3
Pharmacodynamics of NPC-01/IKH-01; Effect of NPC-01/IKH-01 on Sexual Hormone Concentrations in Healthy Female Volunteers
NCT01129102Phase 3
Efficacy and Safety Study of NPC-01 to Treat Dysmenorrhea
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4